These data imply that Tyrobp deletion does not restore neuronal pathways at the gene expression level but may be a novel target by which to reduce the expression of pro-inflammatory pathway-related genes, which alone may mitigate aspects of the mouse HD phenotype. This evidence concerns the gene TYROBP and Huntington disease.